Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Treatment Patterns Among US Veterans Using Remote Electrical Neuromodulation (REN) for Migraine Treatment

NCT: NCT07336420 · COMPLETED

NCT IDNCT07336420
StatusCOMPLETED
Start Date2026-01-09
Completion2026-01-30

Brief Summary

Among US veterans, migraine is a prevalent and disabling neurological disorder, creating a clinical need for effective treatment options. This real-world evidence (RWE) study assessed the use, effectiveness, and safety of the REN wearable for the acute treatment of migraine among veterans, with a primary focus on whether they need rescue medications following REN treatment. Findings from this study may help guide clinical decision-making as veterans and providers craft treatment plans that include non-pharmacologic options.

Frequently Asked Questions

What is Treatment Patterns Among US Veterans Using Remote Electrical Neuromodulation (REN) for Migraine Treatment?

Treatment Patterns Among US Veterans Using Remote Electrical Neuromodulation (REN) for Migraine Treatment is a clinical trial registered under NCT07336420. Current status: COMPLETED.

What is the status of NCT07336420?

The current status of NCT07336420 (Treatment Patterns Among US Veterans Using Remote Electrical Neuromodulation (REN) for Migraine Treatment) is: COMPLETED.

When did Treatment Patterns Among US Veterans Using Remote Electrical Neuromodulation (REN) for Migraine Treatment start?

Treatment Patterns Among US Veterans Using Remote Electrical Neuromodulation (REN) for Migraine Treatment started on 2026-01-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑